Early Stage Venture Primmune Therapeutics Raises Series A of $27400000

About Primmune Therapeutics

Primmune Therapeutics is a Biotechnology company.

Website: Learn more on Primmune Therapeutics’s website

Crunchbase: Follow on Crunchbase

Series A – Primmune Therapeutics

Amount Raised27400000 USD
Announced Date2020-10-27
Equity Only FundingYes
Organization LocationSan Diego, California, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds3
Lead InvestorsCAM Capital, Polaris Partners
Number of Investors7
Number of Partner Investors3

Written by Startup News

Early Stage Venture Sundrive Solar Raises Series A of $5000000

Early Stage Venture Lunchbox Technologies Raises Series A of $20000000